Abstract: A host computer and printer and method of operation wherein the data file describing a document is processed in a manner that creates a frame of data to be transmitted from the host computer to the printer. The data frame contains a data stream which is wrapped in a create font command wrapper so that the printer will be able to process the data frame in some manner. If the printer is operating in a first mode and cannot process the actual stream data, the frame wrapper will allow the printer to process the wrapper and ignore the data stream. If the printer is operating in a second mode and can process the actual data stream, the printer ignores the wrapper and processes the data. The printer will print a message to the user if the printer cannot process the actual data stream. The message informs the user of the printer's inability to process the data stream.

Abstract: A host computer and printer and method of operation wherein the printer is able to switch between two modes of operation. When the printer is powered up, it initializes its internal data registers and printer memory, followed by a check to see if additional firmware, in the form of a cartridge or the like, is added to the printer. If additional firmware is present, the printer turns operational command over to the additional firmware. The present invention, residing in the additional firmware, stores a complete image of the printer state, internal registers, and memory in a location that cannot be accessed by either mode of operation. The present invention compresses the data so that the complete image of the printer state, internal registers, and memory occupies approximately eight KBytes of memory. The storage location may be part of the printer memory itself, or any other suitable location.

Abstract: Apparatus is provided to serve as a phantom for evaluation of prosthetic valves and cardiac ultrasound procedures, wherein a controlled pulsatile flow of a blood-mimicking fluid is passed through a multi-chambered region into which are mounted mitral and aortic valves and adjustably positionable ultrasound transducers. A low friction, drive which involves very low levels of extraneous vibrational inputs, is provided with adjustment of both the volume flow rate of blood-mimicking fluid moved in each operational pulse with further control provided by relatively easily adjusted screws to selectively regulate the systolic and diastolic times of the pulsatile flow generated by a bellows arrangement. Windows made of silicone elastomer material presenting both tissue-equivalent impedance for ultrasound transmission and tissue-equivalent attenuation of the ultrasound are provided in controlled thickness to permit detailed observation of valvular flow parameters of interest, e.g.

Abstract: This invention relates to a method of lowering blood pressure in humans and mammals using 2,6-disubstituted phenyl amidinoureas in which the phenyl ring is additionally substituted by a hydroxy, alkoxy, aralkoxy, alkenyloxy, alkynyloxy, haloacyloxy, or acyloxy group and to novel 2,6-disubstituted phenyl amidinoureas which possess pharmaceutical properties, including blood pressure lowering activity.

Abstract: The laser printer controller for accepting a page of data to be printed in ASCII character format converts the data into a dot-by-dot character pattern for packing in a vertically scrolling partial page bit map. The alignment device within the laser printer controller provides the means for effectively aligning the randomly positioned dot-by-dot character patterns having a first word orientation with respect to its storage boundaries with a second word orientation necessitated by the fixed word storage boundaries of the partial page bit map. The alignment device includes means for partitioning two adjacent words in their first word orientation of the character pattern for alignment with the second word orientation of the page bit map, packing the two respective portions of the adjacent words into a one word format, rotating or manipulating the two word portions within the one word format for proper bit sequence for a single print data word of the second word orientation.

Abstract: This invention relates to a novel class of heterocyclic amidinourea and heterocyclic amidinothiourea compounds wherein the heterocyclic substitution is at the 1-N urea nitrogen atom. These compounds exhibit pharmaceutical activity and may be incorporated into pharmaceutical preparations for producing anti-ulcerogenic, antisecretory, antispasmodic, antimotility, cardiovascular, antidiarrheal or antiparasitic action.

Abstract: A method of inducing blood pressure reduction in humans and mammals by administering 2,6-disubstituted phenyl N-alkyl amidinoureas in which the phenyl ring is additionally substituted by a hydroxy, alkoxy, aralkoxy, alkenyloxy, alkynyloxy, acyloxy or halo acyloxy group and a novel class of amidinourea compounds having pharmaceutical uses, including blood pressure lowering activity.

Abstract: A novel method of treating gastrointestinal, spasmolytic and ulcerogenic disorders by the administration of amidinoureas is disclosed.

Abstract: Novel phenylamidinourea compounds and processes for their preparation are described. These compounds have an effective degree of anti-hypertensive properties and exert activities on the cardiovascular system. A method for the treatment of hypertensive disorders is also described.

Abstract: This invention relates to a method of lowering blood pressure in humans and mammals using 2,6-disubstituted phenyl amidinoureas in which the phenyl ring is additionally substituted by a hydroxy, alkoxy, aralkoxy, alkenyloxy, alkynyloxy, haloacyloxy, or acyloxy group and to novel 2,6-disubstituted phenyl amidinoureas which possess pharmaceutical properties, including blood pressure lowering activity.

Abstract: Novel s-triazine compounds are prepared as derivatives of the corresponding amidinourea and amidinothiourea compounds by reacting with an activated form of an acid amide to give substituted s-triazinones and thiones respectively, of the formula ##STR1## The s-triazinones and thiones are useful derivatives in analyzing for the corresponding amidinourea or amidino thiourea precursors and also have useful pharmacological properties which make them suitable for a variety of medicinal purposes including use as antidiarrheal agents.

Abstract: This invention relates to a novel class of amidinourea and amidinothiourea compounds wherein the urea nitrogen atom is substituted by a heterocyclic alkylene group, and their use in pharmaceutical preparations which are useful for producing anti-ulcerogenic, antisecretory, antispasmodic, antihypertensive, anesthetic, anti-arrhythmic, antidiarrheal and antiparasitic action.

Abstract: A novel method of treating gastrointestinal, spasmolytic and ulcerogenic disorders by the administration of amidinoureas is disclosed.

Abstract: A new class of chemical compounds and their process of preparation is described. These compounds have valuable properties as anti-secretory, anti-spasmodic, anti-ulcerogenic and anti-diarrheal agents.

Abstract: This invention relates to a novel class of heterocyclic amidinourea and heterocylic amidinothiourea compounds wherein the heterocyclic substitution is at the 1-N urea nitrogen atom. These compounds exhibit pharmaceutical activity and may be incorporated into pharmaceutical preparations for producing anti-ulcerogenic, antisecretory, antispasmodic, antimotility, cardiovascular, antidiarrheal or antiparasitic action.

Abstract: This invention describes a new class of 1-amidino-3-phenylthiourea and N'-phenylamidinothiourea compounds wherein the phenyl group is ortho substituted, and processes for their preparation. The phenylamidinothiourea compounds may be incorporated into pharmaceutical preparations which are useful for producing anti-ulcerogenic, antisecretory, antispasmodic, antihypertensive, anti-arrhythmic, anesthetic, antidiarrheal and antiparasitic action.

Abstract: Compounds having the formula: ##STR1## wherein X.sub.1, X.sub.2, R, R.sub.1, R.sub.2 and R.sub.3 are as set forth hereinafter, their preparation and uses as ganglionic blocking agents are disclosed.